Patent ID: 9340517
Filing Date: 2016-05-17
CPC Classification: A61K,A61Q,C07D

Claim Text:
1. A method of treating or controlling a melanocortin 5 receptor (MC5R)-associated condition selected from one or more conditions of the group consisting of acne, seborrhea, and seborrheic dermatitis, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound of formula (Ib): wherein Y is CH X is —C(═O)—; Z is —(CH r is 0 or 1; q is 1, 2, 3, or 4; R wherein R 1c is optionally substituted C 6 -C 18 aryl wherein the C 6 -C 18 aryl is selected from phenyl and naphthyl; R R R R R R each of R wherein each optional substituent is independently selected from the group consisting of F, Cl, Br, I, CH or a pharmaceutically acceptable salt thereof.